Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Exercise
Reported value range
Not reported

Griffin Stephen D. President And CEO

Transaction date Jun 3, 2026
Public filing date Jun 5, 2026
Filing lag Filed 2 days later

ANIK daily price context

Close on/before transaction
$14.41 Jun 3, 2026
First close after public filing
$14.6 Jun 8, 2026
30-day return after filing
+9.79% Through Jul 6, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
12,840 shares
SEC ownership
Direct
Transaction code
M
Form
4
Filing identifier
0001193125-26-259520
Filing cohort

Transactions in this filing

Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$54.31K
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Anika Therapeutics, Inc. ANIK Current Exercise Jun 3, 2026 Not reported
Anika Therapeutics, Inc. ANIK Disposition Jun 3, 2026 $54.31K
Anika Therapeutics, Inc. ANIK Exercise Jun 3, 2026 $0